Immune Checkpoint Dysregulation in Inflammatory Neuropathies: An Exploratory Study

INTRODUCTION/AIMS: Inflammatory neuropathies (IN), such as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune activation, although the precise mechanisms remain unknown. Dysregulated immune checkpoint molecules (ICMs) are known to trigger autoimmunity and inflammation; however, the role of ICMs is not well elucidated in IN. We investigated the gene expression levels of ICMs, such as programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), as well as their respective ligands (CD274, and CD86/CD80) in IN. METHODS: This case-control, cross-sectional, hospital-based study included 67 patients with IN (GBS = 47, CIDP = 20) and equal number of healthy controls. Gene expression levels of PDCD1, CD274, CTLA4, CD86, and CD80 were quantified using ddPCR and correlated with the clinical and electrophysiological parameters. RESULTS: PDCD1, CTLA4, CD274, and CD86 gene expression levels were significantly higher in IN than in healthy controls (p = 0.001, 0.017, 0.001, and 0.006, respectively). In GBS, PDCD1 and CD274 expression levels were significantly increased compared with controls (p = 0.001 and 0.003, respectively), whereas in CIDP, the expression levels of CTLA4, CD274, CD86, and CD80 were higher than in controls (p = 0.050, 0.033, 0.003, and 0.016, respectively). CTLA4, CD86, and CD80 expression levels were greater in CIDP than in GBS (p = 0.049, 0.001, and 0.014, respectively). DISCUSSION: This study demonstrates differential expression of ICMs in GBS and CIDP. The immune checkpoint pathways may play a crucial role in the pathogenesis of inflammatory neuropathies, which warrants further exploration in larger cohorts.

Authors

Institutions

Publication Details

Journal
Muscle & Nerve
Published
2026-11-18
DOI
https://doi.org/10.1002/mus.70458
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immune Checkpoint Dysregulation in Inflammatory Neuropathies: An Exploratory Study

Madhu Nagappa, Monojit Debnath, Pokala Akhil, Sandipan Mondal et al.
1 links
Muscle & Nerve
Peripheral Neuropathies and Disorders
article

Immune Checkpoint Dysregulation in Inflammatory Neuropathies: An Exploratory Study

Madhu Nagappa, Monojit Debnath, Pokala Akhil, Sandipan Mondal, Priyanka Kammar, Saikat Dey, Nandhihaal Ramesh Soumya
article en

Abstract

INTRODUCTION/AIMS: Inflammatory neuropathies (IN), such as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune activation, although the precise mechanisms remain unknown. Dysregulated immune checkpoint molecules (ICMs) are known to trigger autoimmunity and inflammation; however, the role of ICMs is not well elucidated in IN. We investigated the gene expression levels of ICMs, such as programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), as well as their respective ligands (CD274, and CD86/CD80) in IN. METHODS: This case-control, cross-sectional, hospital-based study included 67 patients with IN (GBS = 47, CIDP = 20) and equal number of healthy controls. Gene expression levels of PDCD1, CD274, CTLA4, CD86, and CD80 were quantified using ddPCR and correlated with the clinical and electrophysiological parameters. RESULTS: PDCD1, CTLA4, CD274, and CD86 gene expression levels were significantly higher in IN than in healthy controls (p = 0.001, 0.017, 0.001, and 0.006, respectively). In GBS, PDCD1 and CD274 expression levels were significantly increased compared with controls (p = 0.001 and 0.003, respectively), whereas in CIDP, the expression levels of CTLA4, CD274, CD86, and CD80 were higher than in controls (p = 0.050, 0.033, 0.003, and 0.016, respectively). CTLA4, CD86, and CD80 expression levels were greater in CIDP than in GBS (p = 0.049, 0.001, and 0.014, respectively). DISCUSSION: This study demonstrates differential expression of ICMs in GBS and CIDP. The immune checkpoint pathways may play a crucial role in the pathogenesis of inflammatory neuropathies, which warrants further exploration in larger cohorts.

Muscle & Nerve
National Institute of Mental Health and Neurosciences (IN)
Good health and well-being
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon